Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Acro Biomedical Cash from Operations (Quarterly) : -0.0105M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0105M |
| March 31, 2026 | -0.0498M |
| December 31, 2025 | -0.0254M |
| September 30, 2025 | -0.0544M |
| June 30, 2025 | -0.094M |
| March 31, 2025 | -0.0225M |
| December 31, 2024 | -0.0105M |
| September 30, 2024 | -0.0063M |
| June 30, 2024 | -0.0063M |
| March 31, 2024 | -0.0135M |
| December 31, 2023 | -0.0126M |
| September 30, 2023 | 0.0005M |
| June 30, 2023 | 0.0022M |
| March 31, 2023 | -0.0056M |
| December 31, 2022 | -0.0106M |
| September 30, 2022 | -0.0533M |
| June 30, 2022 | -0.3458M |
| March 31, 2022 | 0.2621M |
| December 31, 2021 | -0.0605M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0645M |
| June 30, 2021 | 0.4328M |
| March 31, 2021 | -0.0084M |
| December 31, 2020 | -0.037M |
| September 30, 2020 | -0.0646M |
| June 30, 2020 | -0.0718M |
| March 31, 2020 | -0.026M |
| December 31, 2019 | -0.0448M |
| September 30, 2019 | 0.0429M |
| June 30, 2019 | -0.0852M |
| March 31, 2019 | 0.122M |
| September 30, 2018 | -0.0042M |
| June 30, 2018 | -0.5124M |
| March 31, 2018 | 0.4044M |
| December 31, 2017 | -0.0283M |
| September 30, 2017 | -0.4162M |
| June 30, 2017 | -0.0176M |
| March 31, 2017 | -0.0295M |
| December 31, 2016 | -0.0001M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Stella Diagnostics, Inc. | -0.9776M |
| DataMeds AI, Inc. | -2.894M |
| Interpace Biosciences, Inc. | 0.098M |
| Medical Marijuana, Inc. | 0.5945M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.0103M |
| Free Cash Flow | -0.1401M |
| Free Cash Flow Per Share (Quarterly) | -0.0002 |
| Free Cash Flow to Equity (Quarterly) | -0.0208M |
| Free Cash Flow to Firm (Quarterly) | -0.0067M |
| Free Cash Flow Yield | -8.97% |